AMENDED AND RESTATED STOCKHOLDERS’ AGREEMENTStockholders’ Agreement • September 22nd, 2005 • Regen Biologics Inc • Surgical & medical instruments & apparatus • Delaware
THIS AMENDED AND RESTATED STOCKHOLDERS’ AGREEMENT, dated as of September 21, 2005 (this “Agreement”), amends and restates that certain Stockholders’ Agreement, dated as of June 21, 2002 (the “Original Agreement”), as previously amended by that certain Amendment to Stockholders’ Agreement, dated as of December 4, 2002, by and among J. Richard Steadman, Sanderling Venture Partners IV Co-Investment Fund, L.P., Sanderling IV Biomedical Co-Investment Fund, L.P., Sanderling IV Venture Management, Sanderling Venture Partners V Co-Investment Fund, L.P., Sanderling V Biomedical Co-Investment Fund, L.P., Sanderling V Limited Partnership, Sanderling V Beteiligungs GmbH & Co. KG, Sanderling V Ventures Management, Sanderling Venture Partners II, L.P., Sanderling Ventures Limited, L.P. (each of the foregoing, a “Stockholder,” and collectively, the “Stockholders”), Centerpulse USA Holding Co. (“Centerpulse”) and ReGen Biologics, Inc. (formerly Aros Corporation), a Delaware corporation (“Parent”). Cap
